Retroperitoneal hematoma following rofecoxib and enoxaparin coadministration in a patient with atrial fibrillation.
Khan
Fahmi Y
FY
Department of Medicine, Hamad General Hospital, Doha, Qatar. fakhanqal@yahoo.co.uk
Hassan
Ibrahim F
IF
Allity
Mustafa H
MH
Khan
Saifatuallah M
SM
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000453:epidemiology; D015897:Comorbidity; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D017984:Enoxaparin / Q000009:adverse effects*; D006406:Hematoma / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D008297:Male; D020370:Osteoarthritis, Knee / Q000453:epidemiology; D012187:Retroperitoneal Space; D012307:Risk Factors; D013450:Sulfones / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants; D016861:Cyclooxygenase Inhibitors; D017984:Enoxaparin; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib